Guangzhou Baiyunshan Pharmaceutical Stock Debt To Equity
| GZPHFDelisted Stock | USD 2.88 0.00 0.00% |
Guangzhou Baiyunshan Pharmaceutical fundamentals help investors to digest information that contributes to Guangzhou Baiyunshan's financial success or failures. It also enables traders to predict the movement of Guangzhou Pink Sheet. The fundamental analysis module provides a way to measure Guangzhou Baiyunshan's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Guangzhou Baiyunshan pink sheet.
Guangzhou |
Guangzhou Baiyunshan Pharmaceutical Company Debt To Equity Analysis
Guangzhou Baiyunshan's Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Current Guangzhou Baiyunshan Debt To Equity | 0.33 % |
Most of Guangzhou Baiyunshan's fundamental indicators, such as Debt To Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Guangzhou Baiyunshan Pharmaceutical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
CompetitionAccording to the company disclosure, Guangzhou Baiyunshan Pharmaceutical has a Debt To Equity of 0.333%. This is 99.38% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The debt to equity for all United States stocks is 99.32% higher than that of the company.
Guangzhou Debt To Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Guangzhou Baiyunshan's direct or indirect competition against its Debt To Equity to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Guangzhou Baiyunshan could also be used in its relative valuation, which is a method of valuing Guangzhou Baiyunshan by comparing valuation metrics of similar companies.Guangzhou Baiyunshan is currently under evaluation in debt to equity category among its peers.
Guangzhou Fundamentals
| Return On Equity | 0.13 | |||
| Return On Asset | 0.0356 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.05 % | |||
| Current Valuation | 5.65 B | |||
| Shares Outstanding | 219.9 M | |||
| Shares Owned By Institutions | 33.99 % | |||
| Price To Earning | 6.77 X | |||
| Price To Book | 0.78 X | |||
| Price To Sales | 0.11 X | |||
| Revenue | 69.01 B | |||
| Gross Profit | 13.19 B | |||
| EBITDA | 5.46 B | |||
| Net Income | 3.72 B | |||
| Cash And Equivalents | 21.72 B | |||
| Cash Per Share | 13.36 X | |||
| Total Debt | 752.81 M | |||
| Debt To Equity | 0.33 % | |||
| Current Ratio | 1.65 X | |||
| Book Value Per Share | 19.33 X | |||
| Cash Flow From Operations | 5.67 B | |||
| Earnings Per Share | 0.35 X | |||
| Number Of Employees | 25.44 K | |||
| Beta | 0.7 | |||
| Market Capitalization | 6.95 B | |||
| Total Asset | 66.12 B | |||
| Z Score | 6.4 | |||
| Annual Yield | 0.04 % | |||
| Net Asset | 66.12 B | |||
| Last Dividend Paid | 0.69 |
About Guangzhou Baiyunshan Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Guangzhou Baiyunshan Pharmaceutical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Guangzhou Baiyunshan using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Guangzhou Baiyunshan Pharmaceutical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Consideration for investing in Guangzhou Pink Sheet
If you are still planning to invest in Guangzhou Baiyunshan check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Guangzhou Baiyunshan's history and understand the potential risks before investing.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |